Cell Metab:挑战常规,小鼠研究证实胰岛素导致肥胖

2013-05-06 ZinFingerNase 生物谷

当吃得太多时,因体内长期含有高水平胰岛素,我们可能变得肥胖。根据一项新的研究,研究人员发现高水平的胰岛素导致小鼠变胖,这一发现挑战了一个普遍持有的观点:水平增加的胰岛素是肥胖和胰岛素耐受性的次级后果。相关研究结果于12月4日发表在Cell Metabolism期刊上。 这项新研究有助于解决这个先有鸡还是先有蛋的难题,因为它证实持续保持低水平胰岛素的动物即便放纵地吃富含高脂肪的食物仍然保持苗条。这

当吃得太多时,因体内长期含有高水平胰岛素,我们可能变得肥胖。根据一项新的研究,研究人员发现高水平的胰岛素导致小鼠变胖,这一发现挑战了一个普遍持有的观点:水平增加的胰岛素是肥胖和胰岛素耐受性的次级后果。相关研究结果于12月4日发表在Cell Metabolism期刊上。

这项新研究有助于解决这个先有鸡还是先有蛋的难题,因为它证实持续保持低水平胰岛素的动物即便放纵地吃富含高脂肪的食物仍然保持苗条。这些研究发现是首次在哺乳动物体内证实血液中循环的胰岛素能够导致肥胖。

加拿大不列颠哥伦比亚大学研究员James Johnson说,这些研究结果也与临床研究证实糖尿病患者长期使用胰岛素往往会导致他们的体重增加。

在这项研究中,Johnson和他的同事们利用小鼠的一种基因变异:它们拥有两个胰岛素基因。基因Insulin1主要出现在胰腺中,而基因insulin2在胰腺和大脑中都存在。通过移除insulin2和改变insulin1基因拷贝数目,研究人员培养出只有空腹血胰岛素水平发生变化的小鼠。当给它们喂食富含高脂肪食物时,含有一个insulin1基因拷贝且保持较低水平空腹胰岛素的小鼠完全不会变得肥胖,甚至不会产生任何食物不振。它们也产生较低水平的炎症,并且它们的肝脏含有较少的脂肪。

尽管用来阻断胰岛素的药物会产生不想要的副作用,但是到目前为止,这并不意味着这些研究发现可能能够用于诊所治疗中。

doi: 10.1016/j.cmet.2012.10.019
PMC:
PMID:

Hyperinsulinemia Drives Diet-Induced Obesity Independently of Brain Insulin Production

Arya E. Mehran, Nicole M. Templeman, G. Stefano Brigidi, Gareth E. Lim, Kwan-Yi Chu, Xiaoke Hu, Jose Diego Botezelli, Ali Asadi, Bradford G. Hoffman, Timothy J. Kieffer, Shernaz X. Bamji, Susanne M. Clee, James D. Johnson

Hyperinsulinemia is associated with obesity and pancreatic islet hyperplasia, but whether insulin causes these phenomena or is a compensatory response has remained unsettled for decades. We examined the role of insulin hypersecretion in diet-induced obesity by varying the pancreas-specific Ins1 gene dosage in mice lacking Ins2 gene expression in the pancreas, thymus, and brain. Age-dependent increases in fasting insulin and β cell mass were absent in Ins1+/−:Ins2−/− mice fed a high-fat diet when compared to Ins1+/+:Ins2−/− littermate controls. Remarkably, Ins1+/−:Ins2−/− mice were completely protected from diet-induced obesity. Genetic prevention of chronic hyperinsulinemia in this model reprogrammed white adipose tissue to express uncoupling protein 1 and increase energy expenditure. Normalization of adipocyte size and activation of energy expenditure genes in white adipose tissue was associated with reduced inflammation, reduced fatty acid spillover, and reduced hepatic steatosis. Thus, we provide genetic evidence that pathological circulating hyperinsulinemia drives diet-induced obesity and its complications.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1887342, encodeId=715a188e34200, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Fri May 17 10:56:00 CST 2013, time=2013-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868643, encodeId=c157186864374, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Jan 16 18:56:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749407, encodeId=74301e4940735, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jul 31 04:56:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895659, encodeId=d589189565933, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Tue Dec 17 13:56:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958877, encodeId=768319588e7ef, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Jun 14 18:56:00 CST 2013, time=2013-06-14, status=1, ipAttribution=)]
    2013-05-17 guojianrong
  2. [GetPortalCommentsPageByObjectIdResponse(id=1887342, encodeId=715a188e34200, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Fri May 17 10:56:00 CST 2013, time=2013-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868643, encodeId=c157186864374, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Jan 16 18:56:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749407, encodeId=74301e4940735, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jul 31 04:56:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895659, encodeId=d589189565933, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Tue Dec 17 13:56:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958877, encodeId=768319588e7ef, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Jun 14 18:56:00 CST 2013, time=2013-06-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1887342, encodeId=715a188e34200, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Fri May 17 10:56:00 CST 2013, time=2013-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868643, encodeId=c157186864374, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Jan 16 18:56:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749407, encodeId=74301e4940735, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jul 31 04:56:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895659, encodeId=d589189565933, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Tue Dec 17 13:56:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958877, encodeId=768319588e7ef, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Jun 14 18:56:00 CST 2013, time=2013-06-14, status=1, ipAttribution=)]
    2013-07-31 baoya
  4. [GetPortalCommentsPageByObjectIdResponse(id=1887342, encodeId=715a188e34200, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Fri May 17 10:56:00 CST 2013, time=2013-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868643, encodeId=c157186864374, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Jan 16 18:56:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749407, encodeId=74301e4940735, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jul 31 04:56:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895659, encodeId=d589189565933, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Tue Dec 17 13:56:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958877, encodeId=768319588e7ef, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Jun 14 18:56:00 CST 2013, time=2013-06-14, status=1, ipAttribution=)]
    2013-12-17 一闲
  5. [GetPortalCommentsPageByObjectIdResponse(id=1887342, encodeId=715a188e34200, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Fri May 17 10:56:00 CST 2013, time=2013-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868643, encodeId=c157186864374, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Jan 16 18:56:00 CST 2014, time=2014-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749407, encodeId=74301e4940735, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jul 31 04:56:00 CST 2013, time=2013-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895659, encodeId=d589189565933, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Tue Dec 17 13:56:00 CST 2013, time=2013-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958877, encodeId=768319588e7ef, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Jun 14 18:56:00 CST 2013, time=2013-06-14, status=1, ipAttribution=)]
    2013-06-14 维他命

相关资讯

Nat Medicine:开发出治疗肥胖的安全有效的激素结合疗法

2012年11月20日--近日,来自印第安纳大学的科学家发现了将两种激素分子结合起来治疗疾病的新方法,这将为治疗肥胖及相关疾病的疗法的开发提供帮助。相关研究成果刊登于国际著名杂志Nature Medicine上。 研究者将消化系统的肽类激素GLP-1与雌激素进行结合,用于对小鼠进行实验研究。肽类激素GLP-1和雌激素都可以进行治疗肥胖以及成年型的糖尿病,将两者结合起来治疗减肥及其它疾病表现出更为

AAOS 2013:肥胖对膝关节置换术后直接医疗费用的影响

研究背景:在美国,肥胖病人的比例持续升高。在年轻和肥胖患者中,膝关节置换(total knee arthroplasty,TKA)手术的数量也在升高。本研究的目的就是观察肥胖对一个大样本TKA患者术后的手术并发症,住院时间以及直接医疗费用的影响。 方法:本研究纳入了8129名患者,其中有6475例行初次TKA以及1654例行TKA翻修术,地点是在美国一家大型的医疗中心,研究时间从2000年1月1

JCEM:骨钙蛋白与骨骼肌胰岛素敏感性有关

动物实验显示骨钙蛋白(OC),特别是羧基化骨钙蛋白(unOC),影响胰岛素敏感性和分泌,但是缺乏来自人类的权威数据。为了确定在超重/肥胖成年人,总OC和unOC是否与胰岛素敏感性和β细胞反应独立相关;糖耐量状态是否影响这些相关性;以及这些相关性是否独立于1型前胶原氨基端肽(P1NP)反映的骨形成。来自英国伯明翰阿拉巴马大学的Barbara A Gower教授及其团队进行了一项研究,该研究发现,在超

社交网站对健康教育显现影响力

    “脸书”(Facebook)等社交网站对公众健康教育的影响正在显现。   一项研究显示,“脸书”爱用者比例较高的地区,坚持健康生活方式、热爱运动的居民比较多,罹患糖尿病的比例也比较低;而另一些地区的居民,访问的网站大都与热门电视节目相关,这部分人群肥胖与糖尿病比例较高。    

JCI:新动物模型研究肥胖是不可逆转的

2012年10月29日--近日,科学家证实小鼠肥胖的时间越长,就越不可能修正自己的饮食习惯,长期活动使得体重正常化的成功的率也较低。 这项发表在10月24日的Journal of Clinical Investigation杂志上的研究揭示了肥胖是不可逆转的。 在新研究中利用了一个新的动物模型,随着时间的推移,尽管采取节食等措施,肥胖老鼠仍然超重。动物模型研究表明,肥胖是一个自我持

JCEM:台湾国防医学院Yi–Jen Hung等发现循环生长停滞特异性蛋白6与肥胖有关

生长停滞特异性蛋白6(Gas6)是由免疫细胞、内皮细胞、血管平滑肌细胞和脂肪细胞分泌的一种维生素K依赖蛋白。临床前研究表明Gas6和其受体TAM家族(Tyro–3,Axl,Mer)可能参与肥胖及其并发症的发病机制,包括全身炎症和胰岛素抵抗。到目前为止,Gas6/TAM系统在儿童肥胖中的临床意义所知甚少。为了确定在台湾青少年中,循环Gas6和可溶性Axl(sAxl)水平是否与肥胖、炎症和胰岛素抵抗状